Skip to main content
OpenTrials
Completed

NCT Number: NCT00252681

Comparison of Two Surgical Treatments for Necrotizing Enterocolitis in Human Infants

The primary purpose of this study is to compare two surgical treatments for perforated necrotizing enterocolitis in very low birth weight babies.

Completed

Looking for future studies?

Notify Me

Key information

Age range

0 year–3 month

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Yale University School of Medicine Section of Pediatric Surgery

New Haven, Connecticut, 06520, United States

About this study

This is a multi-center randomized clinical trial comparing laparotomy vs peritoneal drainage for perforated Necrotizing Enterocolitis. The current literature does not allow an objective comparison between these two methods. A recent comprehensive meta-analysis of all published and much unpublished data regarding the use of these procedures in the treatment of perforated NEC revealed that the degree of bias in assignment to treatment precluded an adequate determination as to the best treatment. The conclusion that only a randomized clinical trial would answer this question has led to this multi-center effort. The relative infrequency of the disease at any one neonatal center has necessitated enrollment of patients at many centers.

Comparison: Premature neonates weighing less than 1500 grams at birth who develop perforated necrotizing enterocolitis are randomized within two birth weight blocks (<1000 gms and 1000 - 1499 gms) for treatment with either laparotomy or primary peritoneal drainage. Daily postoperative clinical care is kept uniform between the two groups by means of a critical care pathway. The primary outcome variable is mortality, i.e. death within 90 days of intervention. The main secondary outcome is short bowel syndrome - defined as the need for chronic parenteral nutrition greater than 3 months following operation.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Birth weight less than 1500 grams
  • Gestational age 24 -33 weeks
  • Diagnosed with necrotizing enterocolitis based on Bell stage II or greater
  • Bowel perforation as evidenced by free intraperitoneal air seen on abdominal radiograph, stool, bile, or pus found at paracentesis or clinical evidence of perforation in the joint opinion of the attending surgeon and neonatologist.

Exclusion criteria

  • Bilateral Grade IV intraventricular hemorrhage
  • Previous abdominal surgery
  • Evidence of gastrointestinal anomaly (i.e. atresia, malrotation etc.)

Treatment and study plan

Laparotomy

Procedure

primary peritoneal drainage

Procedure

Primary outcomes

  1. The primary outcome variable is operative mortality, i.e. death within 90 days of intervention.

Secondary outcomes

  1. The secondary outcome is short bowel syndrome - defined as the need for chronic parenteral nutrition greater than 3 months following operation.

Sponsors and collaborators

Lead sponsor

Yale University

Other

Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  • National Center for Research Resources (NCRR)

Registry information

Official study title

Surgery for Necrotizing Enterocolitis in Human Infants: A Randomized Trial

Important dates

Study start
1999
Study completion
2005
First posted
Nov 11, 2005
Registry last updated
Jul 21, 2006

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.